Six drugs have been accepted for use in NHS Scotland in the latest round of appraisals by the Scottish Medicines Consortium (January 2011).
Degarelix (Firmagon; Ferring) is approved for the treatment of advance hormone-dependent prostate cancer under a patient access scheme.
To read the full story click here.
Extract taken from PJ Online